**Core Concept**
The question is testing the knowledge of muscle relaxants, specifically their use in patients with renal failure. Muscle relaxants are a class of drugs that are used to relax skeletal muscles, and some are more suitable for patients with renal failure due to their pharmacokinetic properties.

**Why the Correct Answer is Right**
The correct answer is Rocuronium, which is a non-depolarizing neuromuscular blocker. It is the muscle relaxant of choice in renal failure because it does not require renal excretion for its elimination. Rocuronium is metabolized by the liver and excreted in the bile, making it a safer option for patients with renal failure. This is in contrast to other non-depolarizing muscle relaxants like pancuronium, which is primarily excreted by the kidneys.

**Why Each Wrong Option is Incorrect**
* **Option A:** Vecuronium is another non-depolarizing muscle relaxant, but it is not the first choice in renal failure due to its similar pharmacokinetic profile to pancuronium.
* **Option B:** Succinylcholine is a depolarizing muscle relaxant that is primarily excreted by the kidneys, making it a less suitable option for patients with renal failure.
* **Option D:** Atracurium is another non-depolarizing muscle relaxant, but it is not the preferred choice in renal failure due to its unpredictable pharmacokinetics and potential for histamine release.

**Clinical Pearl / High-Yield Fact**
When choosing a muscle relaxant for patients with renal failure, it's essential to consider the pharmacokinetic properties of the drug, including its elimination pathway and metabolism. This can help prevent adverse effects and ensure optimal patient outcomes.

**Correct Answer: C. Rocuronium**